Boceprevir in End Stage Renal Disease (ESRD)

NCT02112630 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Hepatitis C Infection
End Stage Renal Disease

Interventions

DRUG: P-IFN alfa 2a
DRUG: P-IFN alfa 2b
DRUG: Ribavirin
DRUG: Boceprevir

Sponsor

Columbia University

Collaborators

[object Object]